190 related articles for article (PubMed ID: 38308545)
1. Diabetic Kidney Disease Without Albuminuria: A New Entity in Diabetic Nephropathy.
Ahmadi N; Amouzegar A
Iran J Kidney Dis; 2024 Jan; 1(1):1-8. PubMed ID: 38308545
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease.
Di Marco M; Scilletta S; Miano N; Marrano N; Natalicchio A; Giorgino F; Di Mauro S; Filippello A; Scamporrino A; Tribulato P; Bosco G; Di Giacomo Barbagallo F; Scicali R; Milluzzo A; Ballirò T; Frittitta L; Castellino P; Purrello F; Piro S; Di Pino A
Cardiovasc Diabetol; 2023 Dec; 22(1):344. PubMed ID: 38093293
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Shi S; Ni L; Gao L; Wu X
Front Endocrinol (Lausanne); 2022; 13():871272. PubMed ID: 35721745
[TBL] [Abstract][Full Text] [Related]
4. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
[TBL] [Abstract][Full Text] [Related]
5. Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?
Laranjinha I; Matias P; Mateus S; Aguiar F; Pereira P; Perneta Santos M; Costa R; Lourenço A; Guia J; Barata JD; Campos L
Nefrologia; 2016; 36(5):503-509. PubMed ID: 27445098
[TBL] [Abstract][Full Text] [Related]
6. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
Satirapoj B; Dispan R; Radinahamed P; Kitiyakara C
BMC Nephrol; 2018 Sep; 19(1):246. PubMed ID: 30241508
[TBL] [Abstract][Full Text] [Related]
7. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes albuminuric and non-albuminuric phenotypes have different morphological and functional ultrasound features of diabetic kidney disease.
Garofolo M; Napoli V; Lucchesi D; Accogli S; Mazzeo ML; Rossi P; Neri E; Del Prato S; Penno G
Diabetes Metab Res Rev; 2023 Jan; 39(1):e3585. PubMed ID: 36273390
[TBL] [Abstract][Full Text] [Related]
9. Trajectories of kidney function in diabetes: a clinicopathological update.
Oshima M; Shimizu M; Yamanouchi M; Toyama T; Hara A; Furuichi K; Wada T
Nat Rev Nephrol; 2021 Nov; 17(11):740-750. PubMed ID: 34363037
[TBL] [Abstract][Full Text] [Related]
10. Real-World Diagnosis and Treatment of Diabetic Kidney Disease.
Rodriguez F; Lee DJ; Gad SS; Santos MP; Beetel RJ; Vasey J; Bailey RA; Patel A; Blais J; Weir MR; Dash R
Adv Ther; 2021 Aug; 38(8):4425-4441. PubMed ID: 34254257
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey.
Duan JY; Duan GC; Wang CJ; Liu DW; Qiao YJ; Pan SK; Jiang DK; Liu Y; Zhao ZH; Liang LL; Tian F; Liu ZS
BMC Nephrol; 2020 Apr; 21(1):115. PubMed ID: 32245423
[TBL] [Abstract][Full Text] [Related]
12. Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate.
Niu J; Zhang X; Li M; Wu S; Zheng R; Chen L; Huo Y; Xu M; Wang T; Zhao Z; Wang S; Lin H; Qin G; Yan L; Wan Q; Chen L; Shi L; Hu R; Tang X; Su Q; Yu X; Qin Y; Chen G; Gao Z; Wang G; Shen F; Luo Z; Chen Y; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Li Q; Mu Y; Zhao J; Bi Y; Ning G; Wang W; Lu J; Xu Y;
Diabetes Metab; 2023 Mar; 49(2):101420. PubMed ID: 36640827
[TBL] [Abstract][Full Text] [Related]
13. The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
Yokoyama H; Araki SI; Kawai K; Yamazaki K; Shirabe SI; Sugimoto H; Minami M; Miyazawa I; Maegawa H;
Diabetes Care; 2020 May; 43(5):1102-1110. PubMed ID: 32144168
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes in patients with type 2 diabetes mellitus-related kidney disease: A Jordanian population cohort study.
Farah R; Alhajahjeh A; Nofal A; Hyasat TB; Abu Jabeh RAH; Suboh LT; Alhawari H; Momani MS; Jaber HJ; AlAwwa I
J Diabetes Complications; 2023 Jun; 37(6):108478. PubMed ID: 37084653
[TBL] [Abstract][Full Text] [Related]
15. Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.
Penno G; Solini A; Orsi E; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Lamacchia O; Scardapane M; Nicolucci A; Pugliese G;
Diabetologia; 2018 Nov; 61(11):2277-2289. PubMed ID: 30032426
[TBL] [Abstract][Full Text] [Related]
16. Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
Zhou Y; Qi C; Li S; Shao X; Mou S; Ni Z
Cell Physiol Biochem; 2018; 51(3):1119-1133. PubMed ID: 30476916
[TBL] [Abstract][Full Text] [Related]
17. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1127-1150. PubMed ID: 31586514
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study.
Nangaku M; Takama H; Ichikawa T; Mukai K; Kojima M; Suzuki Y; Watada H; Wada T; Ueki K; Narita I; Kashihara N; Kadowaki T; Hase H; Akizawa T
Nephrol Dial Transplant; 2023 May; 38(5):1204-1216. PubMed ID: 36002026
[TBL] [Abstract][Full Text] [Related]
19. Serum and Urinary Progranulin in Diabetic Kidney Disease.
Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
[TBL] [Abstract][Full Text] [Related]
20. Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis.
Huang B; Wen W; Ye S
Front Endocrinol (Lausanne); 2022; 13():880930. PubMed ID: 35634488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
